Statement from ALPS on risks of interventions for Peripheral Artery Disease (PAD)

15. July 2023

Recent media reports (see links below) have highlighted serious concerns about the dangers of overuse or misuse of procedures to treat PAD. PAD is a common condition, often causing no or only mild, non-disabling symptoms, but when severe it can lead to major amputation. ALPS is dedicated to promoting the creation and support of multidisciplinary teams to reduce the burden of preventable limb amputations through patient-centric, evidence-based care.

Amputation prevention hinges on early and accurate diagnosis, along with the optimal use of a full range of therapies targeted to the patient’s risk, goals, and stage of disease. Inappropriate and overuse of invasive treatments for PAD can lead to an acceleration of the disease process, a high frequency of repeat procedures, and the potential for deterioration. Patients with risk factors such as diabetes are at the highest risk. Patients and their families should be educated about the signs and symptoms of PAD, receive appropriate medical therapies, lifestyle advice (e.g. smoking cessation, diet and exercise) and surveillance. They must also be fully informed when decision-making about invasive treatments. While this public spotlight on inappropriate treatment is important, published data show that it represents a small minority of vascular specialists. We hope that it will not deter patients who are at risk from seeking timely evaluation that is critical to avoid limb loss.

 

Links:

New York Times: Profiting From Risky Atherectomies That Can Lead To Amputations 

ProPublica:  A CMS Effort To Save Money Enriched Doctors At Patients’ Cost

ProPublica: Artierial Motives – The Big Business Of Clogged Arteries

 

For further details, please contact Alison Evans, ALPS Communication & Marketing Coordinator at alison@alpslimb.org.

About ALPS

We at ALPS have made it our vision to eliminate preventable amputations over the next generation. We believe this can be achieved by promoting interdisciplinary teams to advance the science, clinical care, advocacy, awareness, and education of limb preservation through increased access to resources and specialized care that improves patient-centered outcomes.

 

About ALPS Board of Directors

For more information about ALPS Board of Directors click here.

 

Related Articles

Q&A: Meet the High School Innovator Exhibiting an AI-Powered Diabetic Foot Screening Solution at DFCon 2026

Inspired by his grandfather’s diabetes-related amputation, teenage prospect, Eshaan Naik is tackling one of the most overlooked complications of diabetes. As founder and CEO of SoleIQ Health, he is developing an AI-powered platform that uses smartphone imaging to help identify diabetic foot risks before ulcers develop.
Ahead of exhibiting at DFCon 2026, Naik discusses the personal experience that sparked his interest in limb preservation, why he believes prevention is the future of diabetic foot care, and how technology can help bridge the gap between clinical visits. He also shares his vision for using AI to expand access to monitoring and support earlier intervention for patients at risk of ulceration and amputation.
In this Q&A, Naik reflects on building SoleIQ, learning from clinician feedback, and the opportunity to connect with the researchers, physicians, and innovators working to improve outcomes for patients with diabetic foot disease.

read more